Group 1 - The core point of the news is that Xiangsheng Medical (688358) held its third extraordinary general meeting of shareholders on December 30, 2025, where the profit distribution plan for the first three quarters of 2025 was approved with a high level of agreement from shareholders [1][2][3] - The meeting was attended by 25 shareholders representing 80,361,392 voting rights, which is 71.6708% of the total voting rights of the company [1] - The resolution regarding the profit distribution plan received 99.9987% approval from ordinary shareholders, with 99.9903% approval from minority investors [1][2] Group 2 - On December 31, 2025, Xiangsheng Medical's stock closed at 30.1 yuan, reflecting a 0.27% increase, with a turnover rate of 0.5% and a trading volume of 5,641 shares, amounting to a total transaction value of 16.9273 million yuan [1] - The net outflow of main funds on December 31 was 158.71 thousand yuan, accounting for 9.38% of the total transaction value, while retail investors experienced a net outflow of 82.47 thousand yuan, representing 4.87% of the total transaction value [1][3] - Conversely, speculative funds saw a net inflow of 241.18 thousand yuan, which constituted 14.25% of the total transaction value [1]
股市必读:祥生医疗(688358)12月31日主力资金净流出158.71万元,占总成交额9.38%